Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of teriflunomide for the management of relapsing-remitting multiple sclerosis
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 14, Issue 5, Pages 749-759
Publisher
Informa Healthcare
Online
2015-02-17
DOI
10.1517/14740338.2015.1014795
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- (2014) Amit Bar-Or et al. DRUGS
- Safety considerations when choosing the appropriate treatment for patients with multiple sclerosis
- (2014) Angel P Sempere et al. Expert Opinion On Drug Safety
- Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation
- (2014) Yara Dadalti Fragoso Expert Opinion On Drug Safety
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- (2014) Arianna Sartori et al. EXPERT OPINION ON PHARMACOTHERAPY
- Oral teriflunomide for patients with a first clinical episode suggestive of multiple sclerosis (TOPIC): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Aaron E Miller et al. LANCET NEUROLOGY
- Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2014) Christian Confavreux et al. LANCET NEUROLOGY
- The pill times 2: What every woman with multiple sclerosis should know
- (2014) A. M. Langer-Gould NEUROLOGY
- Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis
- (2014) G. Karlsson et al. NEUROLOGY
- Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis
- (2013) Michael D Wiese et al. Expert Opinion on Drug Metabolism & Toxicology
- Safety evaluation of leflunomide in rheumatoid arthritis
- (2013) Helen I Keen et al. Expert Opinion On Drug Safety
- The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in vitro
- (2013) Li Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial
- (2013) Patrick Vermersch et al. Multiple Sclerosis Journal
- Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
- (2013) A. Bar-Or et al. NEUROLOGY
- PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy
- (2013) Bob W. van Oosten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Manufacturer's Response to Case Reports of PML
- (2013) Marianne T. Sweetser et al. NEW ENGLAND JOURNAL OF MEDICINE
- PML in a Patient Treated with Fumaric Acid
- (2013) Ummehan Ermis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pregnancy outcome in women exposed to leflunomide before or during pregnancy
- (2012) M. Cassina et al. ARTHRITIS AND RHEUMATISM
- Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years
- (2012) Christian Confavreux et al. Multiple Sclerosis Journal
- Teriflunomide added to interferon- in relapsing multiple sclerosis: A randomized phase II trial
- (2012) M. S. Freedman et al. NEUROLOGY
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence supporting a role for dihydroorotate dehydrogenase, bioenergetics, and p53 in selective teriflunomide-induced apoptosis in transformed versus normal human keratinocytes
- (2011) Numsen Hail et al. APOPTOSIS
- Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
- (2011) David B. Clifford ARCHIVES OF NEUROLOGY
- Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped
- (2011) Theo Rispens et al. Multiple Sclerosis Journal
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Birth outcomes in women who have taken leflunomide during pregnancy
- (2010) Christina D. Chambers et al. ARTHRITIS AND RHEUMATISM
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maternal exposure to leflunomide and methotrexate in a patient with adult-onset Still's disease
- (2010) M. Sayarlioglu et al. RHEUMATOLOGY
- Leflunomide-Associated Progressive Multifocal Leukoencephalopathy
- (2008) Megan Rahmlow et al. ARCHIVES OF NEUROLOGY
- A Successful Pregnancy in a Patient with Takayasu's Arteritis
- (2008) Bernhard Kraemer et al. HYPERTENSION IN PREGNANCY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started